Medical research explores microbiome and biomarkers for food allergy treatment

Recent medical research is exploring new frontiers in treating food allergies through microbiome manipulation and advanced biomarkers. A study published in Science Translational Medicine suggests that fecal microbiota transplantation may increase peanut tolerance in some young people with severe allergies. By introducing beneficial bacteria from healthy donors, researchers aim to modify the immune system's response to food proteins.

Separately, a review in Clinical Reviews in Allergy & Immunology highlights the potential of using basophil activation tests and microbiota analysis as biomarkers. These tools could help clinicians predict the severity and reaction thresholds of plant-based food allergies, moving toward a model of personalized precision medicine. While these developments show promise for improving diagnosis and treatment, researchers emphasize that larger clinical trials and validations are still required.